Stuart Sedlack has been appointed senior vice president of business development at Velocity Pharmaceutical Development (VPD). Mr. Sedlack will have primary responsibility for identifying business opportunities to help build the company’s business, as well as partnering and monetizing compounds that have achieved clinical proof of concept. He reports to David Collier, MD, VPD’s chief executive officer and managing director of CMEA Capital.   Mr. Sedlack has significant experience sour...